What is it about?
Across two population-based cohorts, fat mass ratio – a DEXA-based biomarker of fat distribution previously proposed as a means of discriminating partial lipodystrophy – is associated with increased risk of cardiometabolic diseases, fasting insulin, and fasting triglycerides.
Featured Image
Read the Original
This page is a summary of: Relationship of Fat Mass Ratio, a Biomarker for Lipodystrophy, With Cardiometabolic Traits, Diabetes, February 2024, American Diabetes Association,
DOI: 10.2337/db23-0575.
You can read the full text:
Contributors
Be the first to contribute to this page







